Emvision Medical Devices Ltd. · ASX:EMV
Emvision Medical Devices — Investor Presentation (February 2019)
22 slides from Emvision Medical Devices's investor presentation, Feb 5, 2019
Slide 1: Investor Presentation February 2019
www.emvision.com.au For personal use only INVESTOR PRESENTATION February 2019
Slide 2: Medical Imaging Innovation
MEDICAL IMAGING INNOVATION For personal use only Medical imaging has completely transformed modern healthcare Major advancements in imaging only come around every few decades Portability is becoming a critical issue for imaging Electromagnetic (EM) viewed as next generation imaging technology; Fast,
Slide 3: Medical Imaging Devices Using Electromagnetic Microwave Technology
For personal use only MEDICAL IMAGING DEVICES USING ELECTROMAGNETIC MICROWAVE TECHNOLOGY Lead product in development is designed to be a portable, Significant opportunity to change the safe and cost effective brain scanner to rapidly diagnose medial imaging paradigm by bringing and monitor stroke an
Slide 4: Product Pipeline
For personal use only PRODUCT Device Preclinical Regulatory PIPELINE Discovery & Concept Research & Prototype Healthy Human Trials Ethics Clearance Pilot Clinical Trial Pivotal Clinical Trial Clearance & Commercialisation BRAIN SCANNER Identify and monitor H1 2019 H2 2019 2020 stroke and traumatic b
Slide 5: 1st Application: Stroke & Traumatic Brain Injury
For personal use only 1ST APPLICATION STROKE & TRAUMATIC BRAIN INJURY www.emvision.com.au 5
Slide 6: Stroke and Traumatic Brain Injury
TRAUMATIC For personal use only STROKE BRAIN INJURY Stroke is the second leading cause of Traumatic Brain Injury (TBI) is the most frequent death world wide with 1 in 6 people cause of death and disability worldwide 4 having a stroke in their lifetime 1 Motor vehicle accidents, assaults and sporting
Slide 7: Issues with Current Brain Imaging Technology
For personal use only ISSUES WITH CURRENT BRAIN IMAGING TECHNOLOGY 01 02 03 NO POINT-OF-CARE STATIONARY & EXPENSIVE TIME TO TREATMENT There is significant unmet clinical need Current CT and MRI machines are Despite recent advances in life-saving for point of care tools to triage stroke and predomina
Slide 8: EMVision's Brain Scanner
EMVISION’S BRAIN SCANNER For personal use only The Company aims to develop a clinical device that delivers these features FUNCTION Provides reliable identification of blood within the brain to facilitate rapid clinical decision making COST-EFFECTIVE Factoring in both cost differential and life PORTA
Slide 9: Clinical Applications
CLINICAL APPLICATIONS Bringing stoke and traumatic brain injury decision support and monitoring to the patient For personal use only 1st Target Application IN-FIELD TRIAGE + EMERGENCY BED SIDE MONITORING Future versions of the device are Identify stroke and traumatic brain Monitor victims of stroke
Slide 10: Technology Overview
TECHNOLOGY OVERVIEW For personal use only Array of antennas send pulses of low-power electromagnetic waves into the head Waves penetrate tissue in a non-ionizing and harmless manner and get scattered based on the electrical properties of tissue Sensors in the helmet detect these interactions to iden
Slide 11: Development Partners
DEVELOPMENT For personal use only PARTNERS Awarded $2.6M CRC-P non-dilutive cash grant from the Australian Government and secured key academic, clinical and industry partners to assist in advancing the brain scanner program. These partners have also committed to provide a further $910,000 in grant f
Slide 12: 2nd Application: Identifying & Monitoring Liver Disease
For personal use only 2nd APPLICATION IDENTIFYING & MONITORING LIVER DISEASE www.emvision.com.au 12
Slide 13: Liver Disease Is a Looming Public Health Threat
LIVER DISEASE IS A LOOMING PUBLIC HEALTH THREAT For personal use only An estimated 1 in 4 people NAFLD can evolve into NASH is a life threatening NASH is set to become world wide have Non-alcoholic Non-alcoholic disease which can lead to liver the leading cause of fatty liver disease (NAFLD) 1 Steat
Slide 14: Evolving Landscape
EVOLVING For personal use only LANDSCAPE CHALLENGES WITH DIAGNOSIS TREATMENTS BEING DEVELOPED AND MONITORING Pharmaceutical industry have invested CT, MRI and Ultrasound scans of the abdomen several billion dollars in developing are subject to several limitations and can struggle therapeutics for no
Slide 15: EMVision Torso Scanner
EMVISION For personal use only EMVision exploring the feasibility of a non-invasive and TORSO SCANNER cost-effective Torso Scanner to identify the severity and monitor the progression of NAFLD and NASH University of Queensland in partnership with EMvision received a $160,000 QLD Biomedical grant for
Slide 16: Commercial Model, Addressable Markets & Corporate Team
For personal use only COMMERCIAL MODEL ADDRESSABLE MARKETS & CORPORATE TEAM www.emvision.com.au 16
Slide 17: Commercial Model
COMMERCIAL For personal use only MODEL Aiming to be underpinned by robust margins DIRECT CHANNEL DISTRIBUTOR CHANNEL Capital Sales Distribution Equipment is sold upfront with customer Future distribution partners purchase purchasing consumables as required equipment, consumables, accessories and spa
Slide 18: Key Addressable Markets
KEY ADDRESSABLE MARKETS For personal use only North America 48,000 Ambulances Europe 6,000 Hospitals 60,000 Ambulances China 15,000 Hospitals 30,000 Hospitals SECONDARY MARKETS: Aged Care Australia Rural / Remote Cruise Ships 5,200 Ambulances Military Sport 1,300 Hospitals Humanitarian www.emvision.
Slide 19: Team
TEAM Significant experience developing and commercialising medical devices For personal use only Dr Ron Weinberger John Keep Scott Kirkland Prof Stuart Crozier Robert Tiller Chief Executive Officer Executive Chairman Executive Director Clinical Development Advisor Product Design & Former Exec Direct
Slide 20: Capital Structure
For personal use only CAPITAL STRUCTURE ASX: EMV share price since $0.25 IPO 0.50 Current Cash Balance 1 $5.84m 0.45 Shares on issue 57.5m 0.40 Total Options on issue 2 7.5m 0.35 Performance Rights3 0.30 6m 0.25 Market Cap @ $0.45c* 25.8m EV @ $0.45c* $20m 17 December 24 December 31 December 7 Janua
Slide 21: Get in Touch
www.emvision.com.au For personal use only GET IN TOUCH Scott Kirkland Ryan Laws Executive Director, EMvision Non-Exec Director, EMvision E: skirkland@emvision.com.au E: rlaws@emvision.com.au M: +61 413 991 409 M: +61 438 900 255
Slide 22: Disclaimer
DISCLAIMER For personal use only This presentation has been prepared by EMvision Medical Devices Limited (“EMvision” or “the Company”). This presentation is not a financial product or investment advice or recommendation, offer or invitation by any person or to any person to sell or purchase securiti
EMVision Medical Devices — Investor Presentation (February 2019) on 6ix